Dexamethasone
70 NDCs across 15 manufacturers|69 Generic,1 Brand
Dexamethasone is used to treat addison disease, brain edema, bursitis, ulcerative colitis, collagen diseases and dermatitis herpetiformis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 44 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $21 million on Dexamethasone across 1.5 million claims for 882,000 beneficiaries.
Dexamethasone is available as 70 NDCs from 15 manufacturers (69 generic, 1 brand), with NADAC prices from $0.07 to $0.55 per EA — the most expensive product costs about 7.8× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Active FDA drug shortage
19 Dexamethasone presentations are currently listed in FDA's drug shortage database (first posted Feb 8, 2019). Shortages can move NADAC prices in the following weeks.
Total NDCs
70
69G / 1B
Manufacturers
15
competing in market
Price Spread
$0.07 – $0.55
per EA, 64 of 70 NDCs
7d Activity
avg +0.7% WoW · of 70 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Hikma Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Corticosteroid class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
15 manufacturers producing DEXAMETHASONE(1 pricing outlier)
Frequently Asked Questions
What is Dexamethasone used to treat?
Dexamethasone is used to treat addison disease, brain edema, bursitis, ulcerative colitis, collagen diseases and dermatitis herpetiformis, per the National Library of Medicine's MED-RT classification.
When did Dexamethasone become available as a generic?
FDA approved the first generic Dexamethasone (ANDA) on Jan 1, 1982. The Orange Book currently lists 44 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Dexamethasone?
In 2024, Medicare Part D spent $21 million on Dexamethasone across 1.5 million claims for 882,000 beneficiaries.
Is Dexamethasone in shortage?
Yes — FDA's drug shortage database currently lists 19 Dexamethasone presentations with status "Current", first posted Feb 8, 2019.
How many Dexamethasone products are on the market?
The Dexamethasone drug market contains 70 NDCs from 15 manufacturers — 69 generic and 1 brand product.
What is the price range for Dexamethasone?
NADAC reference prices for Dexamethasone range from $0.0707 to $0.5523 per EA — the most expensive product costs about 7.8× the cheapest. 6 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Dexamethasone?
15 manufacturers list Dexamethasone in NADAC. Ranked by number of NDCs, the largest are Hikma Pharmaceuticals USA Inc. (16), ANI Pharmaceuticals, Inc. (7), Viona Pharmaceuticals Inc. (7), Apotex Corp. (7), Advagen Pharma Ltd. (7).
How has the price of Dexamethasone changed recently?
Over the past 7 days, 40 Dexamethasone NDCs rose and 27 fell, with a market-wide average change of +0.7%.